Snowball logo
logo
6733

BioGend Therapeutics Co., Ltd.

6733 TWO
NT$25.05-NT$0.05  (0.2%)
Estimate
EPS
-0.55
Beta
0.081
Growth
Revenue, YoY
8.64%
Net income, YoY
59.77%
FCF, YoY
0.17%
About the company
Ticker
6733
ISIN
Country
Taiwan
Sector (GICS)
Other
BioGend Therapeutics Co., Ltd. engages in the research and development, and sale of orthopedic medical devices and related products. The company offers RevoCart, an autologous cartilage repair system; and SoufCut, an autologous adipose tissue collection system. It develops BiG-001, an osteoinductive bone graft substitute; BiG-006 for lumbar interbody fusion; and BiG-009, an autologous cartilage repair system for articaular cartilage. The company operates in Taiwan, Hongkong, Chinese Mainland, and Malaysia. BioGend Therapeutics Co., Ltd. was founded in 2016 and is based in Taipei, Taiwan.

Frequently asked questions

What sector does BioGend Therapeutics Co., Ltd. (6733) operate in?

BioGend Therapeutics Co., Ltd. belongs to the Other sector and operates in the Biotechnology industry.

What is BioGend Therapeutics Co., Ltd. (6733) current stock price?

As of the latest data, BioGend Therapeutics Co., Ltd. stock price is NT$25.05, with a previous close of NT$25.10. BioGend Therapeutics Co., Ltd. lost -NT$0.05 in the last trading session, representing a -0.2% loss.

What is BioGend Therapeutics Co., Ltd. (6733) current market capitalization?

BioGend Therapeutics Co., Ltd. market cap is approximately 3.36 billion.

What is BioGend Therapeutics Co., Ltd. (6733) Earnings Per Share (EPS)?

The trailing EPS is -NT$0.55.

Does BioGend Therapeutics Co., Ltd. (6733) pay dividends?

No. BioGend Therapeutics Co., Ltd. does not pay a dividend.

What is BioGend Therapeutics Co., Ltd. (6733) beta (volatility) score?

BioGend Therapeutics Co., Ltd. has a beta of 0.081, indicating lower volatility than the overall market.